Stoke Therapeutics, Inc. STOK Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$50M-144% | -$57.93M-453% | -$38.35M-45.1% | -$23.48M+8.6% | $112.88M+528% | ||
| $439K-8.0% | $405K-23.0% | $442K-18.1% | $446K-18.6% | $477K-15.3% | ||
| $8.75M+29.6% | $9.85M+37.9% | $8.04M+7.3% | $7.6M+2.3% | $6.75M+24.8% | ||
| -$60.58M-146% | —— | —— | —— | $131.83M+637% | ||
| $353K+132% | $232K+452% | $132K+28.2% | $154K+235% | $152K+1,167% | ||
| $50.69M+272% | -$61.06M— | $0+100% | -$148.48M-68.2% | $13.63M+36.5% | ||
| $84.33M+6,037% | $92.34M+16,157% | $3.12M-61.8% | $554K-99.5% | $1.37M-20.0% | ||
| $74.44M-49.3% | $0+100% | -$18.15M+58.2% | -$173.35M-1,264% | $146.83M+1,242% | ||
| -$60.94M-146% | —— | —— | —— | $131.68M+636% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Stoke Therapeutics, Inc. generate?
- Stoke Therapeutics, Inc. (STOK) generated $26.4M in operating cash flow over the trailing twelve months.
- What is Stoke Therapeutics, Inc.'s free cash flow?
- After $871.0K of capital expenditures, Stoke Therapeutics, Inc.'s free cash flow was $25.8M over the trailing twelve months, up 132.0% year over year.
- Where does Stoke Therapeutics, Inc.'s cash flow data come from?
- Every line is extracted from Stoke Therapeutics, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
